You have a drug or biologic based on early data. Next, you need a Target Product Profile and an Integrated Product Development Plan. This webinar will review the content of these documents and show how they are written and utilized for success. Reserve Your Spot Today!
Can you avoid a risky trial-and-error approach to find the right path for your poorly soluble molecule by utilizing a CDMO? Download this complimentary Whitepaper to learn more!
How do you maintain control over quality processes and regulated content with the outsourcing of critical functions? Join Mike Jovanis, VP Vault Quality, as we discuss how cloud technology is modernizing quality management. Register to Watch Now!
This 3-part webinar series is specifically geared toward the non-science professional who needs to better understand industry terminology, science, techniques and issues. This series provides an overview of the science and technology used to enable discovery and the processes scientists use to discover new therapeutics. Download now.
In this webinar, key considerations in designing multiparticulate formulations and processing will be discussed with representative case studies. Register to watch now!
Join this webinar to learn how life sciences companies can build positive brand awareness while addressing the new-to-brand patient challenges. Understand how a new medication management solution eases the patient enrollment process at the point-of-care through EHR integration; delivers trial medications to the home; and offers ongoing support to help patients understand their treatment regimen. Register to Watch Now!
Marketing application submissions are the final hurdle before a product makes it to market. This webinar will share tips on regulatory strategy, data integration and readiness, and electronic publishing to help you avoid common pitfalls in the submissions process. Register to Watch Now!
Explore how to overcome the risk and management challenges associated with multilingual communications when conducting global clinical trials and learn how efficient translations can eliminate serious adverse patient reactions as well as trial delays. Download today!
In order to harness the promise of biosimilars, companies must assure competitive edge, maximum profit, and reduced risk. Join leading biosimilars experts from Amgen Inc. and Thomson Reuters for a compelling discussion of the core competencies needed to succeed in today’s biosimilars landscape, and best practices from the companies paving the way. Register to watch now!
With increased costs, regulation and competition, businesses are under pressure to reduce R&D spend while continuing to innovate. The use of collaboration has risen – with many companies managing these partnerships in the Cloud. Our paper explains what you need to know before externalizing R&D.